Example: Heart Attack

Search clinical trials for: Alovudine

Total 39 results

NCT00002260

Completed

An Open-Label, Crossover Study to Assess the Effect of Food on the Oral Bioavailability and Pharmacokinetic Profile of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects

Conditions: HIV Infections
NCT00002271

Completed

An Ascending, Single Oral Dose Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects

Conditions: HIV Infections
NCT00002254

Completed

A Multi-Center, Open-Label, Ascending, Multiple Oral Dose, Safety, Tolerance and Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Patients With Acquired Immune Deficiency Syndrome (AIDS) or AIDS-Related Complex (ARC)

Conditions: HIV Infections
NCT02232581

Completed

Study to Determine the Antiviral Activity and Safety of Alovudine in Nucleoside-experienced HIV-infected Subjects Experiencing Virologic Failure

Conditions: HIV Infections
NCT00572728

Completed

Phase II Study of Fluorine-18 3'-Deoxy-3'-Fluorothymidine (F-18-FLT) in Invasive Breast Cancer

Conditions: Stage IIB Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer
NCT03422731

Recruiting

Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy

Conditions: Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia
NCT04221438

Not yet recruiting

Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement

Conditions: Melanoma of Unknown Primary; Metastatic Malignant Neoplasm in Lymph Node; Pathologic Stage IIIB Cutaneous Melanoma AJCC v8; Pathologic Stage IIIC Cutaneous Melanoma AJCC v8; Pathologic Stage IIID Cutaneous Melanoma AJCC v8; Recurrent Cutaneous Melanoma
NCT04309552

Not yet recruiting

Tumor Hypoxia and Proliferation in Patients With High-Grade Glioma

Conditions: Glioma
NCT03613259

Withdrawn

Fluorothymidine F-18 PET in Diagnosing Patients With Intermediate or High Grade Soft Tissue Sarcoma

Conditions: Stage II Adult Soft Tissue Sarcoma; Stage IIA Adult Soft Tissue Sarcoma; Stage IIB Adult Soft Tissue Sarcoma; Stage IIC Adult Soft Tissue Sarcoma; Stage III Adult Soft Tissue Sarcoma; Stage IV Adult Soft Tissue Sarcoma
NCT03121599

Terminated

18F-FLT (PET/CT) in Pediatrics With Myeloproliferative Neoplasms

Conditions: Essential Thrombocythemia; Primary Myelofibrosis, Fibrotic Stage; Primary Myelofibrosis, Prefibrotic Stage; Polycythemia Vera
NCT03116542

Recruiting

18F-FLT (PET/CT) in Prefibrotic/Early Primary Myelofibrosis and Essential Thrombocythemia

Conditions: Essential Thrombocythemia; Primary Myelofibrosis, Fibrotic Stage; Primary Myelofibrosis, Prefibrotic Stage
NCT02273271

Unknown status

Evaluation of FLT-PET and DWI-MRI in Patients With NSCLC Treated With a Platinum-based Doublet as Preoperative Chemo

Conditions: Non-small Cell Lung Carcinoma
NCT02167204

Completed

18F-FLT PET/CT in Measuring Cell Proliferation in Patients With Brain Tumors

Conditions: Metastatic Malignant Neoplasm in the Brain; Primary Brain Neoplasm; Recurrent Brain Neoplasm
NCT01928186

Completed

FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer

Conditions: Estrogen Receptor Positive; HER2/Neu Negative; Male Breast Carcinoma; Stage IA Breast Cancer; Stage IB Breast Cancer; Stage IIA Breast Cancer; Stage IIB Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer
NCT01713049

Unknown status

18F-FLT PET for Suspicious Findings on Mammography and Breast Ultrasound

Conditions: Breast Neoplasms
NCT01621906

Active, not recruiting

18F-FLT-PET Imaging of the Brain in Patients With Metastatic Breast Cancer to the Brain Treated With Whole Brain Radiation Therapy With or Without Sorafenib: Comparison With MR Imaging of the Brain

Conditions: Metastatic Breast Cancer to the Brain
NCT01065805

Terminated

A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma

Conditions: Brain Cancer; Cancer; Solid Tumor; Lymphoma
NCT01018251

Withdrawn

Positron Emission Tomography in Monitoring Treatment Response in Women With Newly Diagnosed Breast Cancer

Conditions: Adult Women With a New Diagnosis of Invasive Breast Cancer (Have Not Undergone Treatment)
NCT01015131

Completed

18F-FLT-PET in Breast Cancer (MK-0000-139)

Conditions: Breast Cancer
NCT00979810

Completed

Image-Guided Stereotactic Biopsy of High Grade Gliomas

Conditions: Brain Cancer; Glioma
NCT00585741

Terminated

Pilot Study of 18F-FLT PET

Conditions: CNS Brain Metastasis; Head and Neck Cancer; Lung Cancer; Prostate Cancer; Esophageal Cancer
NCT00553748

Completed

Phase I, Open Label, Single Center Safety Study of [F-18]FLT

Conditions: Brain Cancer
NCT00159978

Terminated

Validation of 18F-MISO-PET and 18F-FLT-PET

Conditions: Head and Neck Neoplasms
NCT02392429

Active, not recruiting

FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia

Conditions: Acute Myeloid Leukemia
NCT03546556

Recruiting

18-FLT PET/MR Imaging to Predict Graft Failure and GVHD in Bone Marrow Transplant Patients

Conditions: Graft Vs Host Disease